UK Companies House feature
HALEON UK FINANCE LIMITED
Profile
- Company number
- 09299680
- Status
- Active
- Incorporation
- 2014-11-06
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 64999
- Hubs
- UK Fintech
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Having assessed the principal risks and considered other matters, the Directors are of the opinion that the current level. of activity remains is sustainable. In relation to the potential downside trading scenarios, the considerations have included the accessibility of additional capital and the potential risk to liquidity. The Directors have taken into account that as part of the Group, the Company has already received the necessary letter of support from Haleon Intermediate Holdings Limited as and can take actions to ensure business continuity through operational channels, as well as the ability to manage variable costs. On the basis of those considerations, the Directors believe that it remains appropriate to adopt the going concern basis of accounting in preparing the financial statements.”
Subsidiaries
- Haleon UK Capital PLC · 100% held · England
- Haleon Netherlands Capital B.V. · 100% held · England
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
5 active · 14 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HALEON UK CORPORATE SECRETARY LIMITED | Corporate Secretary | 2022-04-01 | — | — |
| MEHMOOD, Sajid | Director | 2022-03-04 | Jun 1977 | Pakistani |
| ROWE, Michael John | Director | 2022-03-04 | Apr 1969 | British |
| HALEON UK CORPORATE DIRECTOR LIMITED | Corporate Director | 2022-04-01 | — | — |
| HALEON UK CORPORATE SECRETARY LIMITED | Corporate Director | 2022-04-01 | — | — |
Show 14 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Secretary | 2014-11-06 | 2022-04-01 |
| ARISTIDOU, Antrinkos Andrew | Director | 2019-08-19 | 2020-03-10 |
| AROVAH, Hanief Ardiasyah Fadhol | Director | 2020-03-10 | 2021-06-18 |
| BLACKBURN, Paul Frederick | Director | 2014-11-06 | 2016-03-01 |
| BOX, Jonathan Wilson | Director | 2016-06-17 | 2017-11-30 |
| COOPER, Nicholas Ian | Director | 2019-09-11 | 2022-03-04 |
| FOSTER-HAWES, Melanie | Director | 2016-06-17 | 2019-01-15 |
| GODINO ESCOLAR, Mariano Jesus | Director | 2021-06-22 | 2022-03-04 |
| GREEN, Richard | Director | 2019-01-15 | 2020-03-10 |
| HESTLER, Tobias Hannes | Director | 2017-11-30 | 2020-03-10 |
| PROKOPCHUK, Eugene | Director | 2019-03-18 | 2020-03-10 |
| WALKER, Adam | Director | 2015-06-03 | 2016-08-01 |
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Director | 2014-11-06 | 2022-04-01 |
| GLAXO GROUP LIMITED | Corporate Director | 2014-11-06 | 2022-04-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Haleon Uk Enterprises Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-12-13 | Active |
| Consumer Healthcare Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-07-02 | Ceased 2019-12-13 |
| Glaxosmithkline Consumer Healthcare Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2019-07-02 |
Filing timeline
Last 20 of 84 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-09-25 | CH01 | officers | change person director company with change date |
| 2025-08-19 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-08-05 | CH01 | officers | change person director company with change date |
| 2025-08-05 | CH01 | officers | change person director company with change date |
| 2025-07-21 | AA | accounts | accounts with accounts type full |
| 2025-02-26 | RESOLUTIONS | resolution | resolution |
| 2025-02-26 | MA | incorporation | memorandum articles |
| 2024-08-24 | AA | accounts | accounts with accounts type full |
| 2024-08-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-05-31 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-05-31 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2023-11-03 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2023-08-15 | AA | accounts | accounts with accounts type full |
| 2023-06-05 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2023-06-05 | CH02 | officers | change corporate director company with change date |
| 2023-06-05 | CH02 | officers | change corporate director company with change date |
| 2023-06-05 | CH04 | officers | change corporate secretary company with change date |
| 2023-05-25 | CS01 | confirmation-statement | confirmation statement with updates |
| 2023-05-19 | CH04 | officers | change corporate secretary company with change date |
| 2023-05-19 | CH02 | officers | change corporate director company with change date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory